Arch Venture Partners Ix, Llc - Net Worth and Insider Trading
Arch Venture Partners Ix, Llc Net Worth
The estimated net worth of Arch Venture Partners Ix, Llc is at least $1.1 Billion dollars as of 2025-04-29. Arch Venture Partners Ix, Llc is the 10% Owner of Karuna Therapeutics Inc and owns about 3,362,872 shares of Karuna Therapeutics Inc (KRTX) stock worth over $1.1 Billion. Details can be seen in Arch Venture Partners Ix, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Arch Venture Partners Ix, Llc has not made any transactions after 2019-07-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Arch Venture Partners Ix, Llc
Arch Venture Partners Ix, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Arch Venture Partners Ix, Llc owns 6 companies in total, including Beam Therapeutics Inc (BEAM) , Vir Biotechnology Inc (VIR) , and Karuna Therapeutics Inc (KRTX) among others .
Click here to see the complete history of Arch Venture Partners Ix, Llc’s form 4 insider trades.
Insider Ownership Summary of Arch Venture Partners Ix, Llc
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
BEAM | Beam Therapeutics Inc | 2020-02-05 | 10 percent owner |
VIR | Vir Biotechnology Inc | 2021-03-30 | 10 percent owner |
KRTX | Karuna Therapeutics Inc | 2019-07-02 | 10 percent owner |
![]() | ![]() | 2019-02-07 | 10 percent owner |
![]() | ![]() | 2021-02-03 | 10 percent owner |
![]() | ![]() | 2021-06-16 | 10 percent owner |
Arch Venture Partners Ix, Llc Latest Holdings Summary
Arch Venture Partners Ix, Llc currently owns a total of 1 stock. Arch Venture Partners Ix, Llc owns 3,362,872 shares of Karuna Therapeutics Inc (KRTX) as of July 2, 2019, with a value of $1.1 Billion.
Latest Holdings of Arch Venture Partners Ix, Llc
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
KRTX | Karuna Therapeutics Inc | 2019-07-02 | 3,362,872 | 329.83 | 1,109,176,072 |
Holding Weightings of Arch Venture Partners Ix, Llc
Arch Venture Partners Ix, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Arch Venture Partners Ix, Llc has made a total of 0 transactions in Karuna Therapeutics Inc (KRTX) over the past 5 years. The most-recent trade in Karuna Therapeutics Inc is the acquisition of 200,000 shares on July 2, 2019, which cost Arch Venture Partners Ix, Llc around $3 Million.
Insider Trading History of Arch Venture Partners Ix, Llc
- 1
Arch Venture Partners Ix, Llc Trading Performance
GuruFocus tracks the stock performance after each of Arch Venture Partners Ix, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Arch Venture Partners Ix, Llc is -35.67%. GuruFocus also compares Arch Venture Partners Ix, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Arch Venture Partners Ix, Llc within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Arch Venture Partners Ix, Llc's insider trading performs compared to the benchmark.
Performance of Arch Venture Partners Ix, Llc
Arch Venture Partners Ix, Llc Ownership Network
Ownership Network List of Arch Venture Partners Ix, Llc
Ownership Network Relation of Arch Venture Partners Ix, Llc

Arch Venture Partners Ix, Llc Owned Company Details
What does Beam Therapeutics Inc do?
Who are the key executives at Beam Therapeutics Inc?
Arch Venture Partners Ix, Llc is the 10 percent owner of Beam Therapeutics Inc. Other key executives at Beam Therapeutics Inc include Chief Medical Officer Amy Simon , President & CSO Giuseppe Ciaramella , and director & CEO John M. Evans .
Beam Therapeutics Inc (BEAM) Insider Trades Summary
Over the past 18 months, Arch Venture Partners Ix, Llc made no insider transaction in Beam Therapeutics Inc (BEAM). Other recent insider transactions involving Beam Therapeutics Inc (BEAM) include a net sale of 258,765 shares made by John M. Evans , a net sale of 22,608 shares made by Christine Bellon , and a net sale of 114,188 shares made by Giuseppe Ciaramella .
In summary, during the past 3 months, insiders sold 113,636 shares of Beam Therapeutics Inc (BEAM) in total and bought 0 shares, with a net sale of 113,636 shares. During the past 18 months, 1,372,228 shares of Beam Therapeutics Inc (BEAM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,372,228 shares.
Beam Therapeutics Inc (BEAM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Beam Therapeutics Inc Insider Transactions
Arch Venture Partners Ix, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Arch Venture Partners Ix, Llc. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Arch Venture Partners Ix, Llc's mailing address is: Chicago Il 60631.